616 results match your criteria Argon Laser Trabeculoplasty


Intraoperative injection versus sponge-applied mitomycin C during trabeculectomy: One-year study.

Indian J Ophthalmol 2020 Apr;68(4):615-619

Department of Glaucoma, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Tirunelveli, Tamil Nadu, India.

Purpose: To determine the safety and efficacy of mitomycin C (MMC) injection versus sponge during trabeculectomy.

Methods: It is a prospective analysis of patients who underwent trabeculectomy with MMC and followed up for 1 year, divided into two groups, namely, group 1- injection (n = 21), group 2-> sponge (n = 21). The same concentration of MMC was used for both groups. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/ijo.IJO_963_19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210852PMC

Relationship between sleep position and glaucoma progression.

Curr Opin Ophthalmol 2019 Nov;30(6):484-490

Department of Ophthalmology, Stony Brook University, Stony Brook, New York, New York, USA.

Purpose Of Review: As humans spend a considerable portion of life in the horizontal position, it is vital to better understand the effect of sleep position on glaucoma.

Recent Findings: The mean positional increase from the supine position to the lateral decubitus position (LDP) in recent literature is less than 2 mmHg for each eye in its dependent position and less than 1 mmHg in the nondependent position. The right LDP is most commonly favored sleeping position. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/ICU.0000000000000612DOI Listing
November 2019
1 Read

[Diode and argon trabeculoplasty in primary open-angle glaucoma treatment].

Vestn Oftalmol 2019 ;135(4):103-107

Research Institute of Eye Diseases, 11A Rossolimo St., Moscow, Russian Federation, 119021.

Laser trabeculoplasty is one of the methods used to decrease intraocular pressure (IOP) as part of comprehensive glaucoma treatment. Argon laser trabeculoplasty (ALT) and diode laser trabeculoplasty (DLT) are two of the most widely used laser trabeculoplasty techniques. The mechanism of its hypotensive action is based on the effect that laser emission photocoagulate has on trabecular meshwork and subsequent outflow facilitation, but the difference in wavelength and emission energy determine the difference in direct laser action and the features of postoperative clinical appearance. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.17116/oftalma2019135041103DOI Listing
October 2019
1 Read

Argon Laser Iridoplasty For Plateau Iris Syndrome: Long-Term Outcomes of 48 Eyes.

J Glaucoma 2019 09;28(9):767-771

Department of Ophthalmology, Saint Joseph Hospital.

Precis: Argon laser peripheral iridoplasty (ALPI) was performed on 48 eyes with plateau iris syndrome (PIS). Indentation gonioscopy was used to monitor the opening of the iridocorneal angle. Mean intraocular pressure (IOP) at 5 years decreased from 15. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IJG.0000000000001313DOI Listing
September 2019
13 Reads

[Perioperative Anti-inflammatory Treatment in Glaucoma Surgery].

Klin Monbl Augenheilkd 2019 May 16;236(5):647-652. Epub 2019 May 16.

Augenklinik, Universitätsmedizin Mainz.

Many clinical studies have demonstrated the benefit of topical anti-inflammatory medication before and after glaucoma surgery, especially for trabeculectomy, and that they improve the long term outcome. Pre- and postoperative topical steroids improve the outcome of trabeculectomy, but duration and intensity of treatment should be adapted individually. Systemic steroid or oral immunomodulation have significant impact on the outcome in uveitic glaucoma, but not in other glaucoma subtypes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0852-4967DOI Listing
May 2019
4 Reads

Selective laser trabeculoplasty in exfoliative glaucoma eyes with prior argon laser trabeculoplasty.

Acta Ophthalmol 2020 Feb 15;98(1):58-64. Epub 2019 May 15.

Helsinki Retina Research Group, University of Helsinki, Helsinki, Finland.

Purpose: To explore the efficacy of selective laser trabeculoplasty (SLT) within eyes with exfoliative glaucoma and history of prior argon laser trabeculoplasty (ALT).

Methods: A single-centre trial consisting of 47 patients (47 eyes) with uncontrolled exfoliative glaucoma. The main outcome measure was intraocular pressure (IOP) reduction 3 and 9 months after SLT. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/aos.14136DOI Listing
February 2020
5 Reads

Acute primary angle closure-treatment strategies, evidences and economical considerations.

Eye (Lond) 2019 01 22;33(1):110-119. Epub 2018 Nov 22.

Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Hong Kong SAR, People's Republic of China.

Acute primary angle closure requires emergency management that involves a rapid lowering of the intraocular pressure and resolution of relative pupil block - the most common mechanism of angle closure. Emergency strategies for lowering intraocular pressure include medical treatment and argon laser peripheral iridoplasty. Anterior chamber paracentesis and diode laser transcleral cyclophotocoagulation may be considered in special situations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41433-018-0278-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328531PMC
January 2019
42 Reads

Selective Laser Trabeculoplasty versus Argon Laser Trabeculoplasty in Glaucoma Patients Treated Previously with 360° Selective Laser Trabeculoplasty: A Randomized, Single-Blind, Equivalence Clinical Trial.

Ophthalmology 2019 02 29;126(2):223-232. Epub 2018 Sep 29.

Department of Ophthalmology, Western University, Ontario, Canada. Electronic address:

Purpose: The effectiveness of selective laser trabeculoplasty (SLT) was compared with argon laser trabeculoplasty (ALT) in a randomized clinical trial for patients with medically uncontrolled open-angle glaucoma who have previously received 360° SLT.

Design: An active equivalence parallel armed randomized control trial.

Participants: Patients with open-angle glaucoma including pigmentary dispersion syndrome and pseudoexfoliation syndrome were enrolled into the study from 7 different sites across Canada. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2018.09.037DOI Listing
February 2019
27 Reads

A 10-year review of underlying diseases for endothelial keratoplasty (DSAEK/DMEK) in a tertiary referral hospital in Japan.

Clin Ophthalmol 2018 6;12:1359-1365. Epub 2018 Aug 6.

Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan,

Purpose: To report a 10-year review of endothelial keratoplasty (EK) procedures, Descemet's stripping automated endothelial keratoplasty (DSAEK) and Descemet's membrane endothelial keratoplasty (DMEK), and underlying diseases at a tertiary referral hospital in Japan.

Study Design: A single-center, retrospective case series.

Methods: We retrospectively reviewed all medical records of bullous keratopathy (BK) surgically treated by EK (DSAEK/DMEK) at Kanazawa University Hospital from January 2007 to December 2016. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OPTH.S170263DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084067PMC
August 2018
4 Reads

CO laser-assisted sclerectomy surgery compared with trabeculectomy in primary open-angle glaucoma and exfoliative glaucoma. A 1-year follow-up.

Acta Ophthalmol 2018 Aug 14;96(5):e582-e591. Epub 2018 Apr 14.

Department of Ophthalmology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland.

Purpose: To report on the efficacy and safety of CO laser-assisted sclerectomy surgery (CLASS) compared with trabeculectomy in primary open-angle glaucoma and exfoliative glaucoma.

Methods: One hundred and thirty-one patients underwent CLASS (66 patients) or trabeculectomy (65 patients) and were followed up for 12 months. 'Complete success' was defined as intraocular pressure (IOP) between 10 and 18 mmHg and reduced by at least 30% from the baseline without medications, while 'qualified success' was compliant with the above criteria with or without the medications. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/aos.13718DOI Listing
August 2018
13 Reads

A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative Glaucoma.

Adv Ther 2018 05 11;35(5):619-630. Epub 2018 Apr 11.

Department of Ophthalmology, Hospital Universitario "Principe de Asturias," Universidad de Alcalá, Alcalá de Henares, Spain.

In the last decade, selective laser trabeculoplasty (SLT) has been commonly used in the management of several different types of glaucoma, as either primary or adjunct therapy. The technique has an excellent safety profile and is at least as effective as argon laser trabeculoplasty. Although the actual mechanism of action of SLT remains unclear, evidence has shown that it does not induce morphologically evident trabecular meshwork alterations. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12325-018-0695-z
Publisher Site
http://dx.doi.org/10.1007/s12325-018-0695-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960484PMC
May 2018
18 Reads

[Laser Trabeculoplasty in Modern Glaucoma Therapy - a Review].

Klin Monbl Augenheilkd 2019 Oct 11;236(10):1192-1200. Epub 2018 Apr 11.

Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum Regensburg.

Background: Laser trabeculoplasty (LTP) is a well established treatment modality in the management of chronic open angle glaucoma. Nonetheless there is much variation in practice.

Methods: A literature search in the PubMed database was conducted and the most important evidence-based results were summarised. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0577-7925DOI Listing
October 2019
5 Reads

Experience with argon laser trabeculoplasty in Nigerians.

Ghana Med J 2017 Dec;51(4):175-180

Department of Ophthalmology, University of Ibadan College of Medicine, Ibadan, Oyo, Nigeria.

Aim: To report the safety and efficacy of Argon Laser Trabeculoplasty (ALT) in reducing intraocular pressure (IOP).

Settings And Design: This was a retrospective study performed on 25 eyes of 25 patients.

Methods And Materials: Consecutive patients who met the inclusion criteria for ALT were recruited from the ophthalmic clinic of the University College Hospital Ibadan, Nigeria and followed up for a minimum period of six months. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870789PMC
December 2017
17 Reads

Plateau Iris - Therapeutic options and functional results after treatment.

Rom J Ophthalmol 2017 Apr-Jun;61(2):117-122

"Gr. T. Popa" University of Medicine and Pharmacy, Iași, Romania.

We present the therapeutic options and functional results in patients with plateau iris (syndrome or configuration) in consecutive case series. Our study included newly diagnosed patients with acute angle closure by "plateau iris" (configuration or syndrome), between June 2016 and April 2017. Series of 8 consecutive patients met the inclusion criteria, all being females. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710019PMC
http://dx.doi.org/10.22336/rjo.2017.22DOI Listing
July 2018
10 Reads

Evaluating selective laser trabeculoplasty versus argon laser trabeculoplasty in pseudoexfoliation glaucoma patients.

Can J Ophthalmol 2018 02 27;53(1):70-75. Epub 2017 Sep 27.

Department of Ophthalmology & Visual Sciences, Dalhousie University, Halifax, N.S.

Objective: Laser trabeculoplasty effectively reduces intraocular pressure (IOP) in primary open angle glaucoma, with argon laser trabeculoplasty (ALT) and selective laser trabeculoplasty (SLT) showing equivalent outcomes. However, it is unclear which laser modality is more effective in pseudoexfoliation (PXE) glaucoma. This study aims to compare the effectiveness of ALT and SLT in PXE glaucoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcjo.2017.07.004DOI Listing
February 2018
6 Reads
1.299 Impact Factor

Laser Management of Glaucoma in Exfoliation Syndrome.

J Glaucoma 2018 07;27 Suppl 1:S91-S94

Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, AB, Canada.

Argon laser trabeculoplasty as well as selective laser trabeculoplasty can be used in patients with exfoliation syndrome with similar safety and efficacy. However, treatment effect may abruptly reverse and patients need to be followed regularly to monitor intraocular pressure control. Newer laser treatment modalities including micropulse laser trabeculoplasty, titanium sapphire laser trabeculoplasty and pattern scanning trabeculoplasty show promising results but need to be studied in exfoliation patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IJG.0000000000000909DOI Listing
July 2018
8 Reads

Selective laser trabeculoplasty: past, present, and future.

Authors:
A Garg G Gazzard

Eye (Lond) 2018 05 5;32(5):863-876. Epub 2018 Jan 5.

Department of Glaucoma, Moorfields Eye Hospital, London, UK.

Over the past two decades, selective laser trabeculoplasty (SLT) has increasingly become an established laser treatment used to lower intraocular pressure in open-angle glaucoma and ocular hypertensive patients. In this review we trace the origins of SLT from previous argon laser trabeculoplasty and review the current role it has in clinical practice. We outline future directions of SLT research and introduce emerging technologies that are further developing this intervention in the treatment paradigm of glaucoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/eye.2017.273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944654PMC
May 2018
4 Reads

Prospective evaluation of CO laser-assisted sclerectomy surgery (CLASS) with Mitomycin C.

Graefes Arch Clin Exp Ophthalmol 2018 Jan 17;256(1):181-186. Epub 2017 Nov 17.

Clinica Oculistica Università di Genova DiNOGMI - Ospedale Policlinico San Martino, Viale Benedetto XV, 5, 16136, Genoa, Italy.

Purpose: Our purpose was to evaluate the clinical safety and efficacy of CO laser-assisted sclerectomy surgery (CLASS) with Mitomycin C (MMC) in open angle glaucoma (OAG).

Methods: This was a prospective, uncontrolled, interventional case series. All subjects underwent CLASS procedure by a single surgeon. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00417-017-3844-1DOI Listing
January 2018
17 Reads

Palladium-103 plaque radiation therapy for ciliary body melanoma through a functioning glaucoma filtering bleb.

Eur J Ophthalmol 2018 Jan;28(1):119-122

1 Department of Ophthalmology, Ocular Tumor Service, The New York Eye and Ear Infirmary of Mount Sinai, New York, New York - USA.

Purpose: To provide a clinical description of the long-term outcome of a Pd plaque-irradiated ciliary body melanoma with extrascleral extension while attempting to preserve a subadjacent glaucoma filtering bleb.

Methods: A 75-year-old woman with pseudoexfoliative glaucoma for 17 years, 16 years status post argon laser trabeculoplasty, and 15 years status post trabeculectomy in the left eye, was diagnosed with an ipsilateral ciliary body melanoma with visible extrascleral extension. Treatment involved insertion of a Pd radioactive plaque over the functioning trabeculectomy, with removal 7 days later. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/ejo.5001046DOI Listing
January 2018
51 Reads

Evaluation of a Schlemm canal scaffold microstent combined with phacoemulsification in routine clinical practice: Two-year multicenter study.

J Cataract Refract Surg 2017 07;43(7):886-891

From the Dipartimento di Scienze Chirurgiche (Fea), Clinica Oculistica di Torino, Torino, Italy; the Department of Ophthalmology (Rekas), Military Institute of Medicine, Warsaw, Poland; the Manchester Royal Eye Hospital (Au), Central Manchester Foundation Trust, Manchester, United Kingdom.

Purpose: To evaluate the efficacy and the safety of a new Schlemm canal scaffold microstent (Hydrus) combined with cataract surgery in routine clinical practice.

Settings: Clinics in Italy, Poland, and the United Kingdom.

Design: Retrospective case series. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcrs.2017.04.039DOI Listing
July 2017
24 Reads

[Status of Selective Laser Trabeculoplasty (SLT)].

Authors:
Torsten Schlote

Klin Monbl Augenheilkd 2017 Nov 28;234(11):1362-1371. Epub 2017 Jun 28.

Augenheilkunde, Tagesklinik Ambimed, Basel, Schweiz.

Worldwide, in recent years, selective laser trabeculoplasty (SLT) has developed into a very successful therapy for glaucoma. The article provides a review of the literature from PubMed and clinical experience. SLT is equally efficacious to argon laser trabeculoplasty (ALT) and to a first-line glaucoma medication. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0043-102946DOI Listing
November 2017
40 Reads

Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.

Cochrane Database Syst Rev 2017 02 23;2:CD010746. Epub 2017 Feb 23.

Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, 1000 Wall Street, Ann Arbor, Michigan, USA, 48105.

Background: Glaucoma is the international leading cause of irreversible blindness. Intraocular pressure (IOP) is the only currently known modifiable risk factor; it can be reduced by medications, incisional surgery, or laser trabeculoplasty (LTP). LTP reduces IOP by 25% to 30% from baseline, but early acute IOP elevation after LTP is a common adverse effect. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD010746.pub2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477062PMC
February 2017
11 Reads

Maximizing cost-effectiveness by adjusting treatment strategy according to glaucoma severity.

Medicine (Baltimore) 2016 Dec;95(52):e5745

aStatistics Department and Public Health Department, Federal University of Juiz de Fora bOphthalmology Department, Santa Casa de Misericórdia Hospital cGlaucoma Department, Paletta Guedes Ophthalmological Center, Juiz de Fora, MG, Brazil.

Background: The aim of this study is to determine the most cost-effective strategy for the treatment of primary open-angle glaucoma (POAG) in Brazil, from the payer's perspective (Brazilian Public Health System) in the setting of the Glaucoma Referral Centers.

Methods: Study design was a cost-effectiveness analysis of different treatment strategies for POAG. We developed 3 Markov models (one for each glaucoma stage: early, moderate and advanced), using a hypothetical cohort of POAG patients, from the perspective of the Brazilian Public Health System (SUS) and a horizon of the average life expectancy of the Brazilian population. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000005745DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207582PMC
December 2016
6 Reads

Management of glaucoma in pregnancy: risks or choices, a dilemma?

Int J Ophthalmol 2016 18;9(11):1684-1690. Epub 2016 Nov 18.

Department of Ophthalmology, V.M.M.C & Safdarjung Hospital, Newdelhi 110029, India.

The treatment of glaucoma in and around pregnancy offers the unique challenge of balancing the risk of vision loss to the mother as against the potential harm to the fetus or newborn. Most anti-glaucoma drugs ( beta-blockers, prostaglandin analogues, carbonic anhydrase inhibitors topical and systemic, cholinergics, anticholinesterases, and apraclonidine) are considered category C agents and ophthalmologists are usually limited to treating patients with the category B drugs of brimonidine and dipivefrin. Brimonidine is generally the preferred first-line drug in the first, second and early third trimester. Read More

View Article

Download full-text PDF

Source
http://www.ijo.cn/gjyken/ch/reader/view_abstract.aspx?file_n
Publisher Site
http://dx.doi.org/10.18240/ijo.2016.11.24DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145101PMC
November 2016
12 Reads

Ultrasound Biomicroscopy in Pseudophakic Patients with Unexplained Recurrent Hyphema or Vitreous Hemorrhage.

Semin Ophthalmol 2018 14;33(2):260-264. Epub 2016 Dec 14.

a Mayo Clinic Department of Ophthalmology , Rochester , MN , USA.

Purpose: To describe IOL haptic with iris or ciliary body touch on ultrasound biomicroscopy (UBM) in pseudophakic patients with unexplained recurrent hyphema or vitreous hemorrhage.

Methods: Retrospective chart review of 10 patients who presented with unexplained recurrent hyphema and or vitreous hemorrhage.

Results: There were eight posterior chamber intraocular lenses (PCIOL) and two sulcus lenses. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/08820538.2016.1
Publisher Site
http://dx.doi.org/10.1080/08820538.2016.1228984DOI Listing
April 2018
9 Reads

Transpupillary Argon Laser Cyclophotocoagulation in a Refractory Traumatic Glaucoma Patient with Aphakia and Aniridia.

Turk J Ophthalmol 2016 Jan 5;46(1):38-40. Epub 2016 Jan 5.

Ege University Faculty of Medicine, Department of Ophthalmology, İzmir, Turkey.

We present a case of transpupillary argon laser cyclophotocoagulation (TALC) in a patient with traumatic aniridia and aphakia secondary to blunt trauma who had previous bilateral trabeculectomy. Four months after the trauma the patient's intraocular pressure (IOP) rose to 35 mmHg despite topical antiglaucomatous medication. Inferior 180 degrees cyclophotocoagulation was performed with transpupillary argon laser in the first session and his IOP fell to values of 12-17 mmHg. Read More

View Article

Download full-text PDF

Source
http://cms.galenos.com.tr/Uploads/Article_11636/38-40-ing.pd
Publisher Site
http://dx.doi.org/10.4274/tjo.22230DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5076308PMC
January 2016
45 Reads

Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys.

Ophthalmology 2016 10 29;123(10):2085-92. Epub 2016 Aug 29.

Departments of Anesthesia and Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

Purpose: To assess the ability of latanoprost-eluting contact lenses to lower the intraocular pressure (IOP) of glaucomatous eyes of cynomolgus monkeys.

Design: Preclinical efficacy study of 3 treatment arms in a crossover design.

Participants: Female cynomolgus monkeys with glaucoma induced in 1 eye by repeated argon laser trabeculoplasty. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2016.06.038DOI Listing
October 2016
122 Reads

Evaluation of Glaucoma Progression in Large-Scale Clinical Data: The Japanese Archive of Multicentral Databases in Glaucoma (JAMDIG).

Invest Ophthalmol Vis Sci 2016 Apr;57(4):2012-20

Orthoptics and Visual Science, Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Kanagawa, Japan.

Purpose: To develop a large-scale real clinical database of glaucoma (Japanese Archive of Multicentral Databases in Glaucoma: JAMDIG) and to investigate the effect of treatment.

Methods: The study included a total of 1348 eyes of 805 primary open-angle glaucoma patients with 10 visual fields (VFs) measured with 24-2 or 30-2 Humphrey Field Analyzer (HFA) and intraocular pressure (IOP) records in 10 institutes in Japan. Those with 10 reliable VFs were further identified (638 eyes of 417 patients). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1167/iovs.15-19046DOI Listing
April 2016
23 Reads

Where does selective laser trabeculoplasty stand now? A review.

Eye Vis (Lond) 2016 5;3:10. Epub 2016 Apr 5.

Department of Medicine, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium ; Department of Ophthalmology, University Hospital Antwerp, Wilrijkstraat 10, B-2650 Edegem, Belgium.

Background: Chronic treatment of glaucoma can present a challenge in patients who lack the means and/or the discipline to use daily glaucoma medication. We wondered if selective laser trabeculoplasty (SLT) could be a useful alternative.

Methods:

Inclusion Criteria: controlled trials comparing efficacy of SLT in adult patients with any form of open angle glaucoma or ocular hypertension and case reports on side effects of SLT. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40662-016-0041-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820926PMC
April 2016
6 Reads

Current and Future of Laser Therapy in the Management of Glaucoma.

Open Ophthalmol J 2016 29;10:56-67. Epub 2016 Feb 29.

Glaucoma Research Center, Wills Eye Hospital, Philadelphia, PA, USA.

There has been tremendous progress in the past decades in the utilization of lasers for treating patients with glaucoma. This article reviews the use of lasers in different areas of glaucoma, including the shift from argon laser trabeculoplasty (ALT) to selective laser trabeculoplasty (SLT), laser trabeculoplasty as an initial treatment for glaucoma, new laser trabeculoplasty procedures under investigation, and other recent laser treatment modalities such as endoscopic cyclophotocoagulation and laser-assisted deep sclerectomy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1874364101610010056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780519PMC
March 2016
8 Reads

Selective Laser Trabeculoplasty: An Update.

Asia Pac J Ophthalmol (Phila) 2016 Jan-Feb;5(1):63-9

From the University of Colorado School of Medicine, Department of Ophthalmology, Aurora, CO.

Selective laser trabeculoplasty (SLT) is an effective treatment option for the reduction of intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma. The mechanism by which SLT lowers IOP is not completely understood and is likely multifactorial. Published studies indicate that SLT is at least as effective as argon laser trabeculoplasty or medications at lowering IOP in many forms of glaucoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/APO.0000000000000175DOI Listing
September 2016
6 Reads

Management of Primary Angle-Closure Glaucoma.

Asia Pac J Ophthalmol (Phila) 2016 Jan-Feb;5(1):59-62

From the Department of Ophthalmology, The University of Hong Kong, Hong Kong, China.

Primary angle-closure glaucoma (PACG) is a progressive optic nerve degeneration and is defined as a glaucomatous optic neuropathy with associated characteristic enlargement of optic disc cupping and visual field loss that is secondary to ocular hypertension caused by closure of the drainage angle. Angle closure is caused by appositional approximation or adhesion between the iris and the trabecular meshwork. The main treatment strategy for PACG lies in the reduction of intraocular pressure, reopening of the closed angle, and possible prevention of further angle closure. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/APO.0000000000000180DOI Listing
September 2016
31 Reads

The Effect of Laser Trabeculoplasty on Posture-Induced Intraocular Pressure Changes in Patients with Open Angle Glaucoma.

PLoS One 2016 25;11(1):e0147963. Epub 2016 Jan 25.

Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwang-ju, Republic of Korea.

Purpose: To investigate the effect of argon laser trabeculoplasty (ALT) on posture-induced intraocular pressure (IOP) changes in patients with open angle glaucoma (OAG).

Methods: Thirty eyes of 30 consecutive patients with OAG who underwent ALT were prospectively analyzed. The IOP was measured using Icare PRO in the sitting position, supine position, and dependent lateral decubitus position (DLDP) before ALT and at 1 week, 1 month, 2 months, and 3 months after ALT. Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0147963PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726522PMC
July 2016
22 Reads

Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma: A Review of the Literature with Updates on Surgical Management.

J Ophthalmol 2015 29;2015:370371. Epub 2015 Oct 29.

Ophthalmology Unit, NESMOS Department, Sant'Andrea Hospital, University of Rome "Sapienza", Via di Grottarossa 1035-1039, 00189 Rome, Italy.

Pseudoexfoliation syndrome (PES) is a systemic disorder caused by progressive accumulation of extracellular material over various tissues. PES usually determines increased intraocular pressure, changes in the anatomical aspects of the optic nerve, and visual field alterations leading to the diagnosis of pseudoexfoliation glaucoma (PEG). Use of topical medical treatment usually leads to poor results in terms of long-term follow-up but many surgical techniques, such as Argon Laser or Selective Laser Trabeculoplasty, have been proposed for the management of PEG affected patients. Read More

View Article

Download full-text PDF

Source
http://downloads.hindawi.com/journals/joph/2015/370371.pdf
Web Search
http://www.hindawi.com/journals/joph/2015/370371/
Publisher Site
http://dx.doi.org/10.1155/2015/370371DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641922PMC
November 2015
6 Reads

Developments in laser trabeculoplasty.

Br J Ophthalmol 2016 Jan 16;100(1):94-7. Epub 2015 Sep 16.

Department of Ophthalmology, Caritas Medical Centre, Kowloon, Hong Kong.

Laser trabeculoplasty has an increasing important role in the management of glaucoma as more emphasis is placed on minimally invasive therapies. In recent years, the following laser trabeculoplasty technologies have been introduced: micropulse laser trabeculoplasty, titanium-sapphire laser trabeculoplasty and pattern scanning trabeculoplasty. These lasers help to reduce the intraocular pressure (IOP) and the burden of glaucoma medical therapy. Read More

View Article

Download full-text PDF

Source
http://bjo.bmj.com/content/early/2015/09/16/bjophthalmol-201
Web Search
http://bjo.bmj.com/lookup/doi/10.1136/bjophthalmol-2015-3075
Publisher Site
http://dx.doi.org/10.1136/bjophthalmol-2015-307515DOI Listing
January 2016
21 Reads

Secretion of matrix metalloproteinase-3 by co-cultured pigmented and non-pigmented human trabecular meshwork cells following selective laser trabeculoplasty.

Clin Exp Ophthalmol 2016 Jan-Feb;44(1):33-42. Epub 2015 Dec 7.

Department of Pathology, University of Western Ontario, London, Ontario, Canada.

Background: Matrix metalloproteinases (MMPs) are reported to contribute to the mechanism of argon laser trabeculoplasty, but it is unknown whether they are also secreted after selective laser trabeculoplasty (SLT). The aim of this study was to investigate whether human primary trabecular meshwork (HTM) cells secrete MMP-3 after stimulation by SLT. The relationship between SLT and the two principal forms of cell death, apoptosis and necrosis, was also examined. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ceo.12591DOI Listing
September 2016
21 Reads

Primary angle-closure glaucoma: an update.

Acta Ophthalmol 2016 May 27;94(3):217-25. Epub 2015 Jun 27.

Wills Eye Hospital, Philadelphia, PA, USA.

Primary angle-closure glaucoma is potentially a devastating disease, responsible for half of glaucoma-related blindness worldwide. Angle closure is characterized by appositional approximation or contact between the iris and trabecular meshwork. It tends to develop in eyes with shallow anterior chambers, anteriorly positioned or pushed lenses, and angle crowding. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/aos.12784DOI Listing
May 2016
11 Reads

Ultrastructural Changes in Human Trabecular Meshwork Tissue after Laser Trabeculoplasty.

J Ophthalmol 2015 12;2015:476138. Epub 2015 May 12.

Department of Ophthalmology, University of Colorado School of Medicine, 1675 Aurora Court, Mail Stop F-731, Aurora, CO 80045, USA.

Purpose. To compare morphologic changes in human trabecular meshwork (TM) after selective laser trabeculoplasty (SLT) and argon laser trabeculoplasty (ALT). Design. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/476138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443779PMC
June 2015
18 Reads

Management of exfoliative glaucoma: challenges and solutions.

Clin Ophthalmol 2015 22;9:907-19. Epub 2015 May 22.

First and Third Departments of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Exfoliative glaucoma is the most common type of secondary open-angle glaucoma worldwide. It is characterized by high intraocular pressure (IOP) and worse 24-hour IOP characteristics. In order to minimize progression, treatment of exfoliative glaucoma has to provide a low long-term mean IOP and good 24-hour IOP control. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OPTH.S77570DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447167PMC
June 2015
11 Reads

Selective laser trabeculoplasty: current perspectives.

Clin Ophthalmol 2015 11;9:833-41. Epub 2015 May 11.

Westmead Hospital, Westmead, NSW, Australia ; Centre for Vision Research, Westmead Millennium Institute, University of Sydney, Sydney, NSW, Australia ; Save Sight Institute, University of Sydney, Sydney, NSW, Australia.

Selective laser trabeculoplasty (SLT) has been used in the treatment of glaucoma for just over a decade. Here, we review the current literature in terms of suggested mechanism, efficacy, method of treatment, predictors of success, adverse events, repeatability, and cost of SLT. The exact mechanism by which SLT lowers intraocular pressure (IOP) remains unknown although circumstantial evidence has come in many forms in relation to structural alteration; oxidative stress and inflammatory responses; tight junction integrity; proliferative responses; and microbubble formation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OPTH.S53490DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433047PMC
October 2015
7 Reads

Long term efficacy of repeat selective laser trabeculoplasty.

J Ophthalmic Vis Res 2014 Oct-Dec;9(4):444-8

Institute of Ophthalmology and Visual Science, Rutgers-New Jersey Medical School, Newark, New Jersey, USA.

Purpose: To evaluate long term intraocular pressure (IOP) control after repeat selective laser trabeculoplasty (SLT).

Methods: This single center study retrospectively reviews the electronic medical records of patients with open angle glaucoma undergoing repeat SLT. Eyes with prior argon laser trabeculoplasty, or incisional surgery before or during the study period were excluded. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/2008-322X.150814DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329704PMC
February 2015
40 Reads
4 Citations

A Comparison of Resident-performed Argon and Selective Laser Trabeculoplasty in Patients With Open-angle Glaucoma.

J Glaucoma 2016 Mar;25(3):e157-61

*Department of Ophthalmology ‡Francis I. Proctor Foundation §Department of Epidemiology and Biostatistics, Division of Preventive Medicine and Public Health, University of California San Francisco ∥Department of Ophthalmology, San Francisco Veterans Affairs Medical Center, San Francisco, CA †Department of Ophthalmology, Oregon Health and Science University, Portland, OR.

Purpose: To compare intraocular pressure (IOP) reduction and complications of resident-performed argon laser trabeculoplasty (ALT) and selective laser trabeculoplasty (SLT).

Patients And Methods: This was a retrospective, interventional, comparative case series performed at the San Francisco Veterans Affairs Hospital. The study included 77 patients each undergoing 1 resident-performed ALT procedure from April 2006 through November 2009, and 81 patients each undergoing 1 resident-performed SLT procedure from November 2009 through December 2011. Read More

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IJG.0000000000000207DOI Listing
March 2016
27 Reads

Noninvasive glaucoma procedures: current options and future innovations.

Middle East Afr J Ophthalmol 2015 Jan-Mar;22(1):2-9

Department of Ophthalmology, Cairo University, Giza, Egypt.

Noninvasive glaucoma procedures (NIGPs) represent a new dawn in the management of glaucoma. They try to fill the gap between the shortcoming of invasive glaucoma surgeries and antiglaucoma medications. NIGPs were introduced as an adjunct or alternative treatments for glaucoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0974-9233.148342DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302472PMC
April 2015
7 Reads

CANALOPLASTY AFTER LASER TRABECULOPLASTY.

Rom J Ophthalmol 2015 Jan-Mar;59(1):68-70

The paper presents a case of a pseudoexfoliative glaucoma previously treated with argon laser trabeculoplasty in a tertiary center, who was scheduled for canaloplasty in the Ophthalmology Department of the County Hospital Piatra Neamt, Romania. Although the status post laser trabeculoplasty is not among the best indications for canaloplasty, the article confirms the fact that this procedure can also be successfully performed in these cases. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729813PMC
August 2016
7 Reads

Different strategies and cost-effectiveness in the treatment of primary open angle glaucoma.

Clinicoecon Outcomes Res 2014 4;6:523-30. Epub 2014 Dec 4.

Department of Ophthalmology, University Hospital Ayr, South Ayrshire, UK ; Faculty of Medicine, University of Glasgow, Glasgow, UK.

Glaucoma is the second highest cause of blindness worldwide with an estimated half of the glaucoma population unaware of their disease. To date, intraocular pressure is the most important modifiable risk factor and lowering it has been proven to reduce progression of visual field loss associated with glaucoma. Different strategies are available to lower intraocular pressure and include medical, laser, or surgical treatment in the form of topical or systemic medications, argon or selective laser trabeculoplasty, and glaucoma drainage surgery such as trabeculectomy, deep sclerectomy, or other drainage devices. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CEOR.S30697DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259865PMC
December 2014
7 Reads

[Selective Laser Trabeculoplasty in the treatment of chronic open-angle glaucoma: retrospective analysis 12 years after treatment in a cohort of 28 patients].

J Fr Ophtalmol 2014 Dec 14;37(10):812-7. Epub 2014 Nov 14.

Département d'ophtalmologie, hôpital Saint-Joseph, 185, rue Raymond-Losserand, 75014 Paris, France.

Purpose: To determine long-term efficacy of selective Laser Trabeculoplasty (SLT) over 12 years in chronic open-angle glaucoma (OAG) patients.

Methods: In this retrospective study, all patients treated by SLT between 1997 and 1999 for OAG were included and followed up every 6 months. The procedure was performed with a Coherent Selecta 7000 Nd:YAG with 100 ± 10 non overlapping 400 μm spots over 360 degrees centered on the trabecular meshwork. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jfo.2014.09.004DOI Listing
December 2014
8 Reads

Intraocular pressure-lowering medications and long-term outcomes of selective laser trabeculoplasty.

Clin Exp Ophthalmol 2015 May-Jun;43(4):320-7. Epub 2014 Nov 4.

Department of Ophthalmology, Sydney Eye Hospital, Sydney, New South Wales, Australia.

Background: To investigate the effects of current intraocular pressure-lowering medications on the efficacy of selective laser trabeculoplasty.

Design: Retrospective chart review of records from an urban glaucoma clinic in Sydney, Australia.

Participants: Patients who received their first selective laser trabeculoplasty between 2002 and 2005 were studied (grouped from 0 to 3 according to the number of pre-selective laser trabeculoplasty medications, and followed for 5 years). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ceo.12452DOI Listing
January 2016
26 Reads

Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma.

Surv Ophthalmol 2015 Jan-Feb;60(1):36-50. Epub 2014 Jul 2.

Department of Ophthalmology, The University of Hong Kong, Hong Kong SAR, People's Republic of China.

Selective laser trabeculoplasty (SLT) is a relatively new type of laser used in treating open-angle glaucoma (OAG) and is reported to be equally efficacious to a first-line medication and argon laser trabeculoplasty (ALT). We summarize available evidence for considering SLT as an alternative treatment in OAG through systematic review and meta-analysis. Among OAG patients who range from newly diagnosed to those on maximally tolerated medical therapy, SLT results in a 6. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.survophthal.2014.06.006DOI Listing
May 2015
27 Reads